General information |
ACovPid: | ACoVP100321 |
Trivial Name: | IIK |
Amino Acids Sequence: | IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKK-βA-K(C16) |
Length: | |
C-Terminal Modification: | (C16): palmitoyl group;   |
N-Terminal Modification: | None |
Chemical Modification: | βA: β-alanine;   |
Peptide Source: |
Source Description: | Initially, the author aimed to establish combinations of foregrounda-d residues in the heptad repeat moiety. As previous experiments have indicated that alanine residues are strongly biased toward helix formation in peptides,38 the design of the novel lip |
Against Virus: | The Middle East respiratory syndrome coronavirus (MERS-CoV) |
Inhibition Value Type: | EC50 |
Inhibitory Effect: | 0.45 ± 0.13 |
Inhibitory Unit: | µM |
Target Domain Name: | |
Assay: | Cell–cell fusion assay |
Assay Description: | The target cells were Huh-7 cells expressing the MERS-CoV receptor dipeptidyl peptidase 4. The effector cells were 293T/MERS/enhanced GFP protein (EGFP) cells. The 293T/MERS/EGPF cells contained the MERS-CoV S protein gene and the EGFP gene transfected with plasmid. The 293T/EGFP cells expressing only EGFP were employed as negative control cells. Huh-7 cells were plated in 96-well plates (5 × 10^4 cells/well) at 37 °C for 5 h. Then, serially diluted peptide samples were added, followed by the addition of 293T/MERS/EGPF cells or 293T/EGFP cells (1 × 10^4 cells/well). After coculturing at 37 °C for 4 h, the 293T/MERS/EGFP cells and 293T/EGFP cells, either fused or unfused, with Huh-7 cells were counted under an inverted fluorescence microscope (Nikon Eclipse Ti-S). |
Anti-CoV activity in vivo: | |
Reference: | 30192544 |
Comment: | |
3D structure: |
|
Structure Experiment Verified: | |
Similar Peptides: | |